The Funding Stack Problem: How Prime Broker Concentration Became the Next Multi-Strategy Due Diligence Front

The Funding Stack Nobody Was Asking About — Until They Were

Hedge fund gross borrowing reached $6.225 trillion in Q1 2025, a record that represented 26% year-over-year growth and the highest reading since comprehensive data has been collected. Within that stack, the top nine bank prime brokers provided roughly two-thirds of all hedge fund financing, and the top twenty-five controlled an estimated 92% of the market — up from 83.3% a year earlier. Multi-strategy pod shops sat at the apex of the leverage distribution, running at gross leverage ratios around 11.8x as of late 2024, more than double the level of traditional long/short equity strategies and several multiples above the multi-manager mean of a decade earlier.

For most of the past ten years, none of that mattered to the allocator diligence conversation. Prime brokerage was treated as infrastructure — necessary, commoditised, and invisible unless something broke. Something has now broken enough times, and shifted enough structurally, that "who are your primes, and how concentrated?" has moved from a page-twelve operational question to a first-meeting diligence item for every senior allocator reviewing multi-strategy mandates.

The shift is not theoretical. It is driven by four convergent forces — record leverage, concentrated financing relationships, a regulatory regime that is actively reducing bank prime capacity, and a growing academic and central-bank literature that is pricing this concentration as a systemic variable rather than a fund-level concern. For heads of business development at multi-strategy platforms, the practical implication is straightforward: the firms that can articulate their funding stack with specificity — counterparty mix, leverage disclosure, contingency planning, synthetic-versus-cash economics — are converting allocator conversations that less-prepared competitors are losing.

What the Numbers Say

The concentration data is unambiguous. Goldman Sachs, Morgan Stanley, and JPMorgan dominated the institutional prime services league tables through 2025, with Goldman reporting 61–63% penetration among the 150 largest hedge funds and its two closest competitors adding 226 and 210 new fund relationships respectively in a single quarter. Global prime brokerage equity finance revenues were projected at roughly $37 billion for 2025, an 18% increase over 2024 — not because fees fell, but because the underlying balance-sheet demand continued to grow even as capacity tightened.

On the fund side, the Office of Financial Research's hedge fund monitor documented multi-strategy gross leverage rising steadily through 2024 and into 2025, with the November 2025 Federal Reserve Financial Stability Report flagging non-bank financial sector leverage as approaching historic peaks. The New York Fed's primer on hedge funds as non-bank financial intermediaries, published in October 2025, laid out the structural concern in plain terms: a concentrated financing relationship between large, leveraged pod shops and a small number of systemically important banks creates a two-way transmission channel that regulators are now treating as first-order.

The Bank for International Settlements documented the same picture in its March 2024 Quarterly Review, noting that the prime broker–hedge fund nexus had evolved such that the margining, collateral, and funding relationships between a handful of global banks and a handful of large multi-strategy platforms had become a primary determinant of bank tail risk. The BIS has since elaborated, with BIS Bulletin 116 documenting that total non-bank financial intermediation assets now average around 400% of GDP in major advanced economies, concentrating a large share of market leverage outside the regulated banking perimeter but inside prime brokerage financing relationships that cross that perimeter daily.

Archegos Was the Prologue, Not the Postscript

The Archegos Capital Management collapse in March 2021 remains the clearest case study of how prime broker concentration risk plays out in practice — and the reason it is re-entering the diligence conversation five years on is that the structural conditions have tightened, not loosened.

Archegos lost roughly $10 billion to its prime broker syndicate, with Credit Suisse bearing more than €5 billion of that — a loss large enough to contribute materially to the bank's eventual 2023 absorption by UBS. The European Central Bank's post-mortem, summarised by A&O Shearman, identified three concurrent failures: concentration risk (Archegos was large relative to each prime's individual exposure but the primes had no coordinated view), wrong-way risk (the positions' correlations amplified losses at precisely the moment margin was called), and governance failures where revenue-producing relationship teams resisted risk team demands for tighter margin.

Bill Hwang's 2024 sentencing to eighteen years in prison closed the legal chapter, but the structural chapter remained open. New peer-reviewed research published in the Journal of Financial Stability in 2025, Karagiorgis, Anastasiou, Drakos, and Ongena's "The Leverage of Hedge Funds and the Risk of Their Prime Brokers" (also available as SSRN working paper 5310520), documented a strong positive relationship between hedge fund leverage and prime broker stock price crash risk across a 2001–2021 matched panel: a one-standard-deviation increase in hedge fund leverage was associated with roughly a 5% increase in the negative skewness of prime broker bank stock returns. The Hong Kong Monetary Authority extended the finding in its 2025 research memorandum on hedge fund–prime broker linkages, documenting that global systemically important banks function as common counterparties to overlapping sets of large offshore hedge funds — a cross-border contagion channel that did not exist at this scale before the post-crisis consolidation of bulge-bracket prime services.

Basel III Endgame Is the Capacity Squeeze

The regulatory layer is now actively shrinking the bank prime-brokerage balance sheet. Basel III Endgame, the US finalisation of the post-crisis Basel framework, began phase-in on July 1, 2025 with a three-year schedule through June 30, 2028, with global systemically important banks facing an estimated 21% increase in capital requirements and regional banks facing roughly 10%. The Federal Reserve has signalled that an industry-friendly re-proposal is being prepared for early 2026, but even under the softer version the directional pressure on prime brokerage pricing and selectivity is clear and operationally active already.

Two second-order effects matter for multi-strategy platforms. The first is that financing costs — a combination of the risk-free rate, the borrow fee, and an added spread — moved firmly into the top quintile of their five-year range over the course of 2025, with the largest prime brokers openly communicating capacity constraints to clients. The second is that synthetic prime brokerage — financing via total return swaps rather than cash margin — has gained meaningful share as banks' ability to net derivative positions produces lower Basel III capital costs than equivalent cash financing. The Bank of England, in Rebecca Jackson's January 2025 speech on prime brokerage, flagged the same dynamic as a supervisory priority: more of the leverage is moving into structures that regulators find harder to observe, at a moment when the underlying concentration has grown.

For a multi-strategy BD team, this means the "who finances you" question now has a second layer — "and how much of it is synthetic versus cash, and what does that imply if a single prime repapers its terms?" Allocators are asking both.

What Allocators Are Asking Now

The Financial Stability Board's July 2025 final report on leverage in non-bank financial intermediation effectively supplied the questionnaire. It recommended tailored measures including leverage limits, haircuts for non-centrally cleared transactions, and large-exposure caps — and in doing so it gave every institutional allocator a publicly defensible framework for pressing multi-strategy managers on funding structure.

The questions that have moved to the front of allocator diligence conversations, based on the frameworks now being published by specialist advisors such as Resonanz Capital's 2026 quant hedge fund due diligence framework, cluster into four areas:

Counterparty composition and concentration. How many prime brokers does the platform use? What is the top-one and top-three share of financing? How has the mix evolved over three years, and specifically through the Basel III Endgame phase-in period? The allocator is not looking for a specific answer — they are looking for specificity, rate of change, and an articulated rationale.

Leverage disclosure and contingency. What is the gross and net leverage by pod and in aggregate? How quickly can the platform reduce leverage under a repapering event or a prime exit? What is the haircut-stress assumption in the platform's internal liquidity model?

Synthetic versus cash economics. How much of the financing runs through total return swaps? What happens to the strategy's economics if a key swap counterparty widens terms materially or exits? How is the platform thinking about the Basel III-driven shift, and does its answer match what the BIS and Bank of England have publicly flagged?

Archegos-style wrong-way risk. Are individual pods operating with concentrated single-name or single-sector exposure that could simultaneously impair positions and trigger margin calls? How does the risk team monitor cross-pod correlation in stressed states, particularly around month-end and quarter-end margin cycles?

The BD Response — And the Talent Implication

The multi-strategy platforms that are converting allocator conversations on the funding stack share a pattern. They answer in specifics, not reassurances. They disclose their prime concentration ratios voluntarily. They explain their synthetic-cash mix with reference to the regulatory drivers. They name the contingencies they have run and what the results were.

This is not a story about having the "right" funding stack. No platform today has a defensible answer that involves one prime broker — and most have good reasons to run with several, each selected for different collateral, jurisdictional, or product strengths. The allocator conversation is won by the platform that can articulate why its stack is its stack, and what conditions would prompt it to rebalance.

Three talent implications follow, and our search mandates are already reflecting them. Treasury and counterparty risk roles, historically understaffed at even large multi-strategy platforms, are becoming senior hires — with compensation structures pulled closer to portfolio risk roles than to operational controls. Head-of-BD profiles are increasingly expected to be fluent in prime brokerage economics at a level of specificity that would have been a CFO conversation five years ago. And on the research side, cross-asset risk architects who can integrate counterparty stress into the factor model are now a material part of the hiring specification at platforms rebuilding post-March 2026 stress.

Looking Forward

The structural conditions that pushed prime broker concentration onto the allocator questionnaire are not reversing. Basel III Endgame phase-in runs through June 2028 even in its softened form. Multi-strategy leverage is unlikely to materially decline given the competitive dynamics of the platform business. The peer-reviewed and central-bank literature will continue to compound the evidentiary case — the BIS, FSB, ECB, Bank of England, and Federal Reserve are now writing about prime broker–hedge fund concentration with a coordination and specificity that is unusual for the topic.

For heads of business development, the forward task is twofold. First, build the disclosure muscle. The platforms that treat funding-stack disclosure as a differentiation asset rather than a compliance burden are the ones that are going to lead the next wave of large-LP commitments. Second, build the talent layer underneath. The counterparty, treasury, and cross-asset risk roles are now genuine hiring bottlenecks, and the platforms that move on them first will have a structural advantage in an allocator environment where the funding-stack question is not going away.

The question is no longer whether the concentration matters. The Archegos case, the Basel III Endgame schedule, and the 2025–2026 central-bank literature have settled that. The question is whether your platform can answer it, specifically, in the room. The platforms that can are converting. The ones that cannot are losing mandates they did not know were at risk.